Kanada - İngilizce - Health Canada

liquid carbonic inc. - carbon dioxide; air - gas - 50%; 50% - carbon dioxide 50%; air 50% - other miscellaneous therapeutic agents

Kanada - İngilizce - Health Canada

liquid carbonic inc. - carbon dioxide; oxygen - gas - 7%; 93% - carbon dioxide 7%; oxygen 93% - miscellaneous therapeutic agents

ABD - İngilizce - NLM (National Library of Medicine)

energique, inc. - oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), hekla lava (unii: c21158iirk) (hekla lava - unii:c21158iirk), hydrofluoric acid (unii: rgl5ye86cz) (fluoride ion - unii:q80vpu408o), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838), toxicode - oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml - may temporarily relieve symptoms of chronic inflammation of the back and bone injury. **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve symptoms of chronic inflammation of the back and bone injury. **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

ABD - İngilizce - NLM (National Library of Medicine)

bioactive nutritional, inc. - oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), hydrofluoric acid (unii: rgl5ye86cz) (fluoride ion - unii:q80vpu408o), hekla lava (unii: c21158iirk) (hekla lava - unii:c21158iirk), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), silicon - oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml - for temporary relief of injuries to bones, tendons, and muscles. for temporary relief of injuries to bones, tendons, and muscles.

ABD - İngilizce - NLM (National Library of Medicine)

king bio inc. - oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), hekla lava (unii: c21158iirk) (hekla lava - unii:c21158iirk), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), silicon dioxide (unii: etj7z6xbu4) (s - oyster shell calcium carbonate, crude 10 [hp_x] in 59 ml - uses a natural aid for bone discomforts: malnutrition of bones, bone injuries, bone pain, fragile bones, weak spine. uses a natural aid for bone discomforts: - malnutrition of bones - bone injuries - bone pain - fragile bones - weak spine

ABD - İngilizce - NLM (National Library of Medicine)

apotheca company - oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), hekla lava (unii: c21158iirk) (hekla lava - unii:c21158iirk), hydrofluoric acid (unii: rgl5ye86cz) (fluoride ion - unii:q80vpu408o), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838), toxicode - oyster shell calcium carbonate, crude 30 [hp_x] in 1 ml - indications:   for temporary relief of symptoms of chronic inflammation of the back and bone injury. indications: for temporary relief of symptoms of chronic inflammation of the back and bone injury.

ABD - İngilizce - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 150 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: - treatment of acute manic and mixed episodes in patients 7 years and older [see clinical studies (14)] - maintenance treatment in patients 7 years and older [see clinical studies (14)]. lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate tablet or capsule or lithium citrate products [see adverse reactions (6)]. risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. there are concerns for maternal and/or neonatal lithium toxicity during late pre

ABD - İngilizce - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 150 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate capsule [see adverse reactions (6)]. risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. there are concerns for maternal and/or neonatal lithium toxicity during late pregnancy and the postpartum period [see clinical considerations]. published animal developmental and toxicity studies in mice and rats report an increased incidence of fetal mortality, decreased fetal weight, increased fetal skele

ABD - İngilizce - NLM (National Library of Medicine)

cardinal health 107, llc - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 300 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate tablet or capsule or lithium citrate products [see adverse reactions (6)]. risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. there are concerns for maternal and/or neonatal lithium toxicity during late pregnancy and the postpartum period [see clinical considerations]. published animal developmental and toxicity studies in mice and rats report an increased incidence of fetal mortality, decreas

ABD - İngilizce - NLM (National Library of Medicine)

international medication systems, limited - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis – e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time int